CSCO
$117.89 at the check
NO TRADE

Kairon's answer on CSCO: no clear edge.

Checked Jun 29, 2026 at $117.89 · time frame 3-6 months · confidence low
Result check on Dec 26, 2026: open.
Get the result by email

The 10-second check

Loading filings…

Both sides

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

Argument 1 - [Category: Profitability & Growth] [HIGH conviction]
Evidence: Net Income (TTM) $11.96b, with +37.1% YoY EPS growth (latest quarterly). FCF margin is 15.29%, and ROE is 25.23%.
Thesis: The company exhibits exceptional profitability and efficient capital utilization, with both FCF margin (15.29%) and ROE (25.23%) significantly exceeding the 15% threshold for a high score. The robust +37.1% YoY EPS growth in the latest quarter demonstrates strong and accelerating earnings generation, supporting a premium valuation.

Argument 2 - [Category: Financial Health & Earnings Quality] [HIGH conviction]
Evidence: Debt/Equity ratio is 0.64x, Interest Coverage is 10.61x, and Net Debt/EBITDA is 1.42x. Cash Conversion (OCF/Net Income) is 1.09x, and the Accruals Ratio is -0.0085.
Thesis: The company maintains a healthy and conservatively managed balance sheet, indicated by low debt ratios and strong interest coverage. Critically, the Cash Conversion ratio of 1.09x and a negative Accruals Ratio of -0.0085 point to high earnings quality, ensuring that reported profits are robustly backed by cash flow, mitigating concerns about accounting manipulation.

Argument 3 - [Category: Technical Trend & Relative Strength] [HIGH conviction]
Evidence: CSCO is 36.33% above its 200-day SMA ($83.46), and its 90-day Relative Strength vs SPY is +35.05%. Quant's tsmom_12_1, tsmom_6_1, and tsmom_3_1 momentum drivers are all scored at +100.
Thesis: The stock demonstrates a powerful and established long-term uptrend, significantly outperforming the broader market over the past two to three months. This persistent outperformance, confirmed by multiple strong bullish momentum signals from the Quant engine, indicates robust investor demand and sustained upward price trajectory. The broader market regime is also BULL (SPY +6.13% above 200MA).

Argument 4 - [Category: Risk/Reward & Mean Reversion Potential] [MEDIUM conviction]
Evidence: The technical R/R Ratio is 4.30:1, with an Upside Target of $130.00 and a Stop-loss reference of $110.00. The Monte Carlo analysis projects an expected forward return of 5.82% over a 63-day horizon with a 66.58% probability of an upward move. Quant's mean reversion signals (bollinger_pos +100, zscore_reversion +78, short_term_reversal +75) are strongly bullish.
Thesis: Despite recent short-term weakness, the stock presents a highly favorable technical risk/reward profile. Probabilistic analysis from Monte Carlo suggests a high likelihood of positive returns. Furthermore, the strong mean-reversion signals from the Quant engine suggest that the current dip (price at $113.77, just below the lower Bollinger Band of $114.01) is likely a temporary pullback offering an attractive entry point before a bounce.

BEAR COUNTER-ARGUMENTS

Bear said: The valuation appears expensive with a TTM P/E of 39.35x and a Forward P/E of 24.71x, alongside a FCF Yield of 2.00%.
Counter: While the TTM P/E of 39.35x and FCF Yield of 2.00% are higher than market averages, the strong +37.1% YoY EPS growth in the latest quarter justifies a premium. The PEG Ratio of 1.58x, while not indicating extreme undervaluation, suggests a reasonable valuation when considering the company's growth profile. Furthermore, the exceptional FCF margin of 15.29% and ROE of 25.23% demonstrate high-quality earnings and efficient capital deployment, which typically command higher multiples. The forward P/E of 24.71x reflects expected continued growth.

Bear said: There is negative Free Cash Flow growth of -11.93% YoY in the latest quarter, coupled with revenue growth of +11.96%, indicating that revenue is growing faster than operating cash flow, raising concerns about earnings quality.
Counter: While FCF growth was negative -11.93% YoY in the latest quarter, the company still generated a robust FCF margin of 15.29% (TTM FCF $9.29b on TTM Revenue $60.75b), indicating strong underlying cash generation from sales. The Cash Conversion (OCF/Net Income) of 1.09x further demonstrates that net income is converting efficiently into operating cash flow. The Accruals Ratio of -0.0085, indicating negative accruals, points to high earnings quality and suggests that the FCF decline might be temporary or related to investment cycles rather than a structural issue with cash generation.

Bear said: Goodwill at 47.23% of total assets is above the 40% threshold, which can be a red flag.
Counter: While goodwill at 47.23% of total assets is a notable figure, the company's strong profitability (Net Income $11.96b, ROE 25.23%) and substantial cash position ($7.08b) provide a significant buffer against potential impairment risks. The low Net Debt/EBITDA of 1.42x and high Interest Coverage of 10.61x also demonstrate overall financial strength and capacity to manage its balance sheet, including acquired assets effectively.

Bear said: Recent technical indicators show short-term weakness, including a -2.32% relative strength vs SPY over 30 days, a bearish MACD cross, price ($113.77) just below the lower Bollinger Band ($114.01), and high volume on down days. The HMM also identifies a bearish regime (P(bull) 0.02) with elevated volatility.
Counter: The identified short-term weakness represents a temporary pullback rather than a reversal of the dominant trend. The stock's long-term trend remains strongly bullish, being 36.33% above its 200-day SMA and exhibiting 90-day relative strength of +35.05% vs SPY. The current dip is precisely what the Quant engine's strong Mean Reversion signals (bollinger_pos +100, zscore_reversion +78, short_term_reversal +75) identify as a potential entry point. Despite the HMM's bearish regime and elevated volatility (20d/120d ratio of 1.07), the Monte Carlo analysis still projects a 5.82% expected forward return with a 66.58% probability of an upward move, suggesting the current short-term weakness presents a favorable probabilistic risk/reward balance.

BULL THESIS INVALIDATION LEVEL
The bull thesis breaks if: The stock closes below $108.69 (50-day SMA support) for two consecutive days, or if the next earnings report shows EPS growth below 10% YoY alongside negative FCF growth for a second consecutive quarter.

OVERALL BULL CONVICTION: HIGH (8-10)
Justify: The bull case is supported by three HIGH conviction arguments rooted in robust fundamental profitability, strong balance sheet health, high earnings quality, and powerful long-term technical trends. While valuation and short-term FCF growth present legitimate risks, these are significantly mitigated by accelerating EPS growth, strong cash conversion, and a favorable probabilistic outlook from quantitative models that identify the current dip as a mean-reversion opportunity within a broader bullish market regime. The Quant Engine's overall verdict is BULLISH with 73% agreement, reinforcing the conviction.
Bear Analyst: As the Bear Analyst, my role is to rigorously challenge the bullish assumptions and highlight the underlying risks with cold, hard data. While the company exhibits certain strengths, a deeper dive reveals significant vulnerabilities that the market may be underpricing.

## BEAR CASE RISKS

Risk 1 - [Category: Valuation] [HIGH conviction]
Evidence: The stock trades at a Trailing P/E of 39.35x, a Forward P/E of 24.71x, an EV/EBITDA of 28.78x, and an FCF Yield of 2.00%. These multiples are significantly elevated compared to typical growth companies with a revenue growth rate of +11.96% YoY and a negative FCF growth rate.
Risk: The market is assigning a premium valuation that is not fully justified by the underlying growth and cash flow generation. Any deceleration in revenue growth, sustained negative FCF growth, or a general market de-rating could lead to a significant multiple compression.
Quantified downside: If the Forward P/E compresses from 24.71x to a more conservative 18x (still a premium for ~12% revenue growth given FCF issues), the stock could decline approximately 27.2%. If the FCF Yield expands from 2.00% to 3.5% (still implying a high valuation), the stock could decline approximately 42.8%.

Risk 2 - [Category: Fundamental - Earnings Quality & Cash Flow Deterioration] [HIGH conviction]
Evidence: Revenue grew +11.96% YoY in the latest quarter, while Free Cash Flow growth was negative -11.93% YoY. This directly triggers the "Revenue growing >2x faster than operating cash flow: PRESENT" red flag in the Fundamentals Report.
Risk: This significant divergence between revenue growth and FCF contraction indicates a deterioration in the quality of earnings and the company's ability to convert reported profits into actual cash. While Net Income grew +37.1% YoY, the negative FCF growth suggests that this earnings growth may not be sustainable or is being achieved at the expense of cash flow.
Quantified downside: If this trend persists and the market re-rates the company to reflect lower cash generation quality, a sustained FCF decline could lead to a 20-30% re-rating. If FCF generation continues to lag, and the market demands a higher FCF yield, say 3.00% from the current 2.00%, the stock could decline 33.3%.

Risk 3 - [Category: Technical Breakdown & Regime Shift] [HIGH conviction]
Evidence: Recent technicals show a -2.32% relative strength vs SPY over 30 days, a bearish MACD cross (MACD 2.06 below signal 3.70, MACDH -1.64), and the price ($113.77) is currently just below the lower Bollinger Band ($114.01). Furthermore, the HMM P(bull) is very low at 0.02, suggesting a bearish regime, and the volatility regime (20d/120d ratio) is 1.07, indicating elevated short-term volatility. High volume on down days (51.6M shares on 2026-06-26) suggests significant selling pressure.
Risk: Despite the long-term trend, the stock is experiencing significant short-term weakness and a potential regime shift. The bearish MACD cross, negative relative strength, and elevated volatility, combined with a bearish HMM signal, suggest that the current dip may not be a temporary mean-reversion opportunity but the beginning of a deeper correction.
Quantified downside: A break below the critical 50-day SMA support ($108.69) could trigger a move towards the 200-day SMA ($83.46), representing a 26.6% decline from the current price of $113.77.

Risk 4 - [Category: Balance Sheet - Goodwill Impairment Risk] [MEDIUM conviction]
Evidence: Goodwill constitutes 47.23% of total assets, exceeding the 40% threshold identified as a red flag in the Fundamentals Report.
Risk: While the company has a strong cash position ($7.08b) and low debt ratios, this high proportion of goodwill on the balance sheet exposes it to significant impairment risk if acquired assets underperform, or if growth forecasts are not met. Such an event could severely impact net income and shareholder equity.
Quantified downside: A significant impairment event, hypothetically leading to a 10% reduction in Net Income from the current $11.96b, could result in a 10% decline in stock price, assuming valuation multiples remain constant.

## BULL COUNTER-ARGUMENTS

Bull said: Argument 1 - [Category: Profitability & Growth] [HIGH conviction]
Evidence: Net Income (TTM) $11.96b, with +37.1% YoY EPS growth (latest quarterly). FCF margin is 15.29%, and ROE is 25.23%.
Thesis: The company exhibits exceptional profitability and efficient capital utilization, with both FCF margin (15.29%) and ROE (25.23%) significantly exceeding the 15% threshold for a high score. The robust +37.1% YoY EPS growth in the latest quarter demonstrates strong and accelerating earnings generation, supporting a premium valuation.
Counter: While profitability metrics like Net Income ($11.96b), FCF margin (15.29%), and ROE (25.23%) are indeed strong, the bull overlooks the critical divergence where revenue growth (+11.96% YoY) is significantly outpacing Free Cash Flow growth (-11.93% YoY). This negative FCF growth, despite positive EPS growth, suggests that the "accelerating earnings generation" is not translating into actual cash flow, raising questions about the sustainability and quality of reported profits.

Bull said: Argument 2 - [Category: Financial Health & Earnings Quality] [HIGH conviction]
Evidence: Debt/Equity ratio is 0.64x, Interest Coverage is 10.61x, and Net Debt/EBITDA is 1.42x. Cash Conversion (OCF/Net Income) is 1.09x, and the Accruals Ratio is -0.0085.
Thesis: The company maintains a healthy and conservatively managed balance sheet, indicated by low debt ratios and strong interest coverage. Critically, the Cash Conversion ratio of 1.09x and a negative Accruals Ratio of -0.0085 point to high earnings quality, ensuring that reported profits are robustly backed by cash flow, mitigating concerns about accounting manipulation.
Counter: While the balance sheet metrics (Debt/Equity 0.64x, Interest Coverage 10.61x, Net Debt/EBITDA 1.42x) and Cash Conversion (1.09x) are favorable for *reported* net income, the "Revenue growing >2x faster than operating cash flow: PRESENT" red flag is a direct contradiction to the claim of high earnings quality. This indicates a structural issue where the *growth* in cash flow is significantly lagging revenue growth, suggesting that reported profits, while converting well *from net income*, are not being generated efficiently from sales at the operating level. Furthermore, the Goodwill at 47.23% of total assets represents a significant balance sheet risk despite otherwise healthy debt ratios.

Bull said: Argument 3 - [Category: Technical Trend & Relative Strength] [HIGH conviction]
Evidence: CSCO is 36.33% above its 200-day SMA ($83.46), and its 90-day Relative Strength vs SPY is +35.05%. Quant's tsmom_12_1, tsmom_6_1, and tsmom_3_1 momentum drivers are all scored at +100.
Thesis: The stock demonstrates a powerful and established long-term uptrend, significantly outperforming the broader market over the past two to three months. This persistent outperformance, confirmed by multiple strong bullish momentum signals from the Quant engine, indicates robust investor demand and sustained upward price trajectory. The broader market regime is also BULL (SPY +6.13% above 200MA).
Counter: While the long-term trend appears strong (36.33% above 200-day SMA, +35.05% 90-day RS), the bull ignores critical *recent* technical deterioration and conflicting regime signals. The stock has shown -2.32% relative strength vs SPY over the last 30 days, a bearish MACD cross (MACD 2.06 below signal 3.70), and high volume on down days (51.6M shares on 2026-06-26), indicating increasing selling pressure. Most importantly, the Quant engine's HMM P(bull) is a very low 0.02, clearly identifying a bearish regime, directly contradicting the overall bullish market regime and suggesting that the internal dynamics of CSCO are shifting against the trend.

Bull said: Argument 4 - [Category: Risk/Reward & Mean Reversion Potential] [MEDIUM conviction]
Evidence: The technical R/R Ratio is 4.30:1, with an Upside Target of $130.00 and a Stop-loss reference of $110.00. The Monte Carlo analysis projects an expected forward return of 5.82% over a 63-day horizon with a 66.58% probability of an upward move. Quant's mean reversion signals (bollinger_pos +100, zscore_reversion +78, short_term_reversal +75) are strongly bullish.
Thesis: Despite recent short-term weakness, the stock presents a highly favorable technical risk/reward profile. Probabilistic analysis from Monte Carlo suggests a high likelihood of positive returns. Furthermore, the strong mean-reversion signals from the Quant engine suggest that the current dip (price at $113.77, just below the lower Bollinger Band of $114.01) is likely a temporary pullback offering an attractive entry point before a bounce.
Counter: The favorable R/R ratio is based on an arbitrary $130 target and $110 stop-loss, which does not account for the potential for a deeper correction. While mean reversion signals are strong, the context is crucial: the HMM P(bull) of 0.02 indicates a strong bearish regime, and the volatility regime of 1.07 points to elevated short-term volatility, suggesting that mean reversion could lead to a deeper retest of support rather than a quick bounce. The Monte Carlo's 66.58% P(up) is not overwhelmingly strong, and its 5th-95th percentile band ranges from -13.68% to 27.89%, highlighting substantial downside risk that is being underplayed. The recent high volume on down days (51.6M shares) indicates significant institutional selling that could overwhelm short-term mean reversion.

## RED FLAGS FROM ANALYST REPORTS
- Revenue growing >2x faster than operating cash flow: PRESENT
- Goodwill >40% of total assets: PRESENT (47.23%)

## BEAR THESIS CONFIRMATION SIGNAL
The bear thesis accelerates if: The stock closes below $112.86 (Support 1, recent low) for two consecutive days, or if the next earnings report shows Free Cash Flow growth remaining negative for a second consecutive quarter while revenue growth decelerates below 10% YoY.

## OVERALL BEAR CONVICTION: MEDIUM (5-7)
Justify: My conviction is MEDIUM, strongly leaning towards HIGH, given the confluence of extreme valuation multiples (TTM P/E 39.35x, FCF Yield 2.00%), a critical divergence in revenue vs. FCF growth (Revenue +11.96% YoY vs FCF -11.93% YoY), and a clear technical breakdown in the short-term with a bearish HMM regime signal (P(bull) 0.02). While long-term momentum is noted, the recent selling pressure (high volume on down days) and conflicting quantitative signals (strong bullish momentum vs. strong bearish regime) suggest significant underlying weakness. The two explicit red flags from the fundamentals report further underscore the risks. The potential downside, quantified across multiple risks (27-43%), is substantial, making the current risk/reward highly unfavorable for long positions.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on CSCO

2 past checks: 1 directional calls (0 right, 1 wrong), 1 × wait (afterwards −4.3 % on average). Measured by price since each check, no costs. How we measure · Every 'not now' answer

Jun 29, 2026 · Wait at $117.89 · anyone who bought anyway: −4.3 %wait
Oct 1, 2025 · Long at $117.09 · −3.6 % sincewrong

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$112.86
Resistance$130.00
Horizon3-6 months

Executive summary

CSCO exhibits strong relative strength and EPS growth, but is challenged by an expensive valuation and negative free cash flow. Critically, the proposed trade structure includes a stop-loss that violates a non-negotiable firm rule regarding risk percentage, leading to a definitive no-trade decision. Additional concerns include high goodwill and short-term technical weakness.

Investment thesis

Despite CSCO's compelling 90-day relative strength (+35.05% vs SPY) and robust quarterly EPS growth (+37.1% YoY), the overall picture is too conflicted for a trade. Valuation is a significant concern, with a TTM P/E of 39.35x and a Forward P/E of 24.71x, coupled with negative Free Cash Flow growth (-11.93% YoY). Technical signals like a bearish MACD cross and high volume on down days suggest the current dip carries more risk than a mere optimal entry point. The decisive factor for the no-trade decision is the proposed stop-loss of $110.00 (2.53% risk), which directly violates the firm's strict requirement for a 7-12% risk range, making the trade indefensible irrespective of its potential R/R.

Valuation assessment

CSCO appears expensive with a TTM P/E of 39.35x and a Forward P/E of 24.71x, which is above historical averages and peers, leaving little margin for error. This high valuation is compounded by negative Free Cash Flow growth of -11.93% YoY, suggesting potential issues with cash generation despite strong EPS growth.

Key risks

The primary risk is the proposed stop-loss violating a hard rule, making the trade indefensible. Other risks include stretched valuation, negative FCF growth, high goodwill (47.23% of total assets) carrying impairment risk, and short-term technical weakness indicated by a bearish MACD cross and high volume on down days.

AI-generated. Created 2026-06-29 17:39 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $117.89. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure · every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum · Privacy · Terms · Disclaimer